Log in

Relevant bibliographies by topics / Glasgow Antipsychotic Side-effect Scale (GASS)

Contents

Journal articles

Academic literature on the topic 'Glasgow Antipsychotic Side-effect Scale (GASS)'

Author: Grafiati

Published: 4 June 2025

Last updated: 1 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Glasgow Antipsychotic Side-effect Scale (GASS).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Glasgow Antipsychotic Side-effect Scale (GASS)"

1

Sterritt, James. "Monitoring side-effects of antipsychotics using the glasgow antipsychotic side-effect scale." BJPsych Open 7, S1 (2021): S106—S107. http://dx.doi.org/10.1192/bjo.2021.315.

Full text

Abstract:

AimsAntipsychotic drugs frequently produce side-effects which represent common reasons for noncompliance. National guidelines, published by the National Institute of Care and Health Excellence, the Royal College of Psychiatrists, and the Maudsley Prescribing Guidelines in Psychiatry, stipulate that patients prescribed antipsychotic drugs should be reviewed for side-effects on a weekly basis. This completed audit cycle, conducted on a mixed acute general adult psychiatric ward, examined whether patients were being assessed for side-effects of antipsychotic drugs using a standardised, self-repor

APA, Harvard, Vancouver, ISO, and other styles

2

Hasni, Dita, Vivinia Rahmi Andika Putri, and Mutiara Anissa. "Identification of Antipsychotic Side Effects with Glassgow Antipsychotic Side-Effect Scale (GASS)." Journal of Health Science and Prevention 4, no. 2 (2020): 85–90. http://dx.doi.org/10.29080/jhsp.v4i2.268.

Full text

Abstract:

Schizophrenia is ranked 4th of the top 10 diseases that burden worldwide. If the population of Indonesia reaches 200 million, it estimates that around two million have Schizophrenia. Based on Data from the World Health Organization (WHO), it estimates that around 24 million people worldwide have schizophrenia.2 the American Psychiatric Association (APA) were reported the incidence of Schizophrenia in the United States is about 1% of the adult population with a total of more than 2 million people. Schizophrenic patients were treated by antipsychotic agents that act to inhibit dopamine receptors

APA, Harvard, Vancouver, ISO, and other styles

3

Rodolico, Alessandro, Carmen Concerto, Alessia Ciancio, et al. "Validation of the Glasgow Antipsychotic Side-Effect Scale (GASS) in an Italian Sample of Patients with Stable Schizophrenia and Bipolar Spectrum Disorders." Brain Sciences 12, no. 7 (2022): 891. http://dx.doi.org/10.3390/brainsci12070891.

Full text

Abstract:

Antipsychotics are a class of psychotropic drugs that improve psychotic symptoms and reduce relapse risk. However, they may cause side effects (SE) that impact patients’ quality of life and psychosocial functioning. Therefore, there is a need for practical tools to identify them and possibly intervene. The objective of the present study was to translate into Italian the Glasgow Antipsychotic Side Effect Scale (GASS), which is suggested as the questionnaire of choice to collect SE reported by patients treated with antipsychotics. We administered the GASS and the Udvalg for Kliniske Undersøgelse

APA, Harvard, Vancouver, ISO, and other styles

4

Singh, Hardeep, Maryam Syed, Vimal Mannali, and Ekta Sharma. "Assessing Adherence: Audit of Glasgow Antipsychotic Side-Effect Scale Completion for Patients on Antipsychotic Depot Injections at Guildford CMHRS SABP." BJPsych Open 10, S1 (2024): S169—S170. http://dx.doi.org/10.1192/bjo.2024.435.

Full text

Abstract:

AimsTo evaluate the current use of the GASS scale in monitoring patients on antipsychotic depot medications at Guildford CMHRS, we conducted a comprehensive assessment and compared it with trust guidelines. The guidelines recommend GASS scale completion at specific intervals: 12 weeks and 6 months post-initiation, annually thereafter, and at each dose titration.MethodsWe conducted a review of patient depot charts and SystmOne notes for individuals on antipsychotic depot medications, in accordance with trust guidelines. Cases were randomly selected from the total number of patients on these med

APA, Harvard, Vancouver, ISO, and other styles

5

Bock, Marlene S., Oona N. van Achter, David Dines, et al. "F28. CLINICAL VALIDATION OF THE GLASGOW ANTIPSYCHOTIC SIDE EFFECT SCALE (GASS)." Schizophrenia Bulletin 45, Supplement_2 (2019): S265. http://dx.doi.org/10.1093/schbul/sbz018.440.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Sodiya, Olusegun, Adewole Adegoke, Geanina Ilinoiu, and Clare Morgans. "Clinical Audit on the Measurement of Antipsychotic Side Effects Using Rating Scales (GASS, LUNSERS, and SESCAM) in Community Settings." BJPsych Open 9, S1 (2023): S182—S183. http://dx.doi.org/10.1192/bjo.2023.475.

Full text

Abstract:

AimsThis clinical audit aimed to assess if monitoring of side effect of antipsychotics is adhered to using the Trust and National institute of clinical excellence (NICE) guidelines.One of the determinants of prognosis in schizophrenia is compliance to medications. Hence, the importance to monitor patient's tolerability of side effects when they are on antipsychotic medications. Several patients during episodes of relapse have reported that experience of side effects were their main reasons for defaulting on their medications. This underpins the importance to monitor patients’ tolerability of s

APA, Harvard, Vancouver, ISO, and other styles

7

Haw, Camilla, Ayesha Muthu-Veloe, Mark Suett, Oghodafetite Ibodor, and Marco Picchioni. "Monitoring antipsychotic side effects: a competed audit cycle conducted in a secure hospital." Journal of Forensic Practice 18, no. 3 (2016): 182–88. http://dx.doi.org/10.1108/jfp-06-2015-0034.

Full text

Abstract:

Purpose – The purpose of this paper is to describe a completed audit cycle of the assessment and documentation of antipsychotic side effects reported by patients in a secure hospital setting. Design/methodology/approach – The initial audit was carried out in 2012. As a result of the findings clinicians were recommended to use a brief structured side effect monitoring guide (the Glasgow Antipsychotic Side-Effect Scale (GASS-m)). The audit was repeated in 2015. Findings – Of the 41 patients notes included in the initial audit, for only one (2.4 per cent) was there evidence of a systematic and st

APA, Harvard, Vancouver, ISO, and other styles

8

Paton, Cristina, Siggi Hammond, James Hills, Leah Jones, and Eugene Wong. "GASS-tly side effects: antipsychotic monitoring for inpatients across NHS Lanarkshire." BJPsych Open 7, S1 (2021): S97. http://dx.doi.org/10.1192/bjo.2021.293.

Full text

Abstract:

AimsBest practice in the prescribing of antipsychotic therapy includes monitoring for medication side effects. National guideline SIGN 131 advises the use of a validated side effect scale, for example the Glasgow Antipsychotic Side-effect Scale (GASS). Local recommendation in NHS Lanarkshire advises that patients prescribed antipsychotic therapy should be offered GASS at each contact and after initiation or titration. We aimed to improve compliance with antipsychotic side effect monitoring for inpatients in general adult psychiatry across two hospital sites in NHS Lanarkshire.MethodWe conducte

APA, Harvard, Vancouver, ISO, and other styles

9

Waterman, Harry, Hanna Zaborowska, and Julie Taylor. "Side-Effect Monitoring for Patients on Depot Antipsychotic Medication Within a Community Treatment Team." BJPsych Open 9, S1 (2023): S186—S187. http://dx.doi.org/10.1192/bjo.2023.483.

Full text

Abstract:

AimsTo determine whether the community treatment team (CTT) were meeting the following three trust standards for patients receiving antipsychotic depot medication: 1. 100% of patients should have side effects monitored using a validated scoring system in the form of the Glasgow Antipsychotic Side-effect Scale (GASS) once yearly. 2. 100% of patients should have had a GASS completed ever. 3. 100% of patients with a completed GASS should have this document available in full. Additionally adherence to these measures was compared to the previous year's audit to assess for change following intervent

APA, Harvard, Vancouver, ISO, and other styles

10

Tait, Andrew, and Eugene Wong. "Completion Audit of Inpatient Glasgow Anti-Psychotic Side-Effect Scale (GASS) Forms." BJPsych Open 10, S1 (2024): S264—S265. http://dx.doi.org/10.1192/bjo.2024.636.

Full text

Abstract:

AimsSide-effects are a recognised burden of all medications and are linked to poor compliance. In psychiatry, poor compliance can result in a relapse and significant deterioration in mental health. This has an impact on both the patient and the wider healthcare system. It has been speculated that if patients had more control/recognition of side-effects, compliance would increase.GASS is a self-rating scale for side-effects of antipsychotic medication. It has the added effect of being able to stratify side-effects by their severity and biological system involved (Central Nervous System (Sedatin

APA, Harvard, Vancouver, ISO, and other styles

More sources

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!